Patents by Inventor Rance B. Lefebvre

Rance B. Lefebvre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine against papillomatous digital dermatitis (PDD)
    Publication number: 20030086947
    Abstract: This invention relates to the diagnosis and prevention of ungulate diseases caused by the spirochete bacteria Treponema. The invention specifically relates to isolated cultures of this spirochete and isolated nucleic acids and proteins.
    Type: Application
    Filed: March 1, 2000
    Publication date: May 8, 2003
    Applicant: TOWNSEND AND TOWNSEND AND CREW
    Inventors: Richard L. Walker, Deryck H. Read, David W. Hird, Rance B. Lefebvre, Steven L. Berry, James S. Cullor, Hank M. Lefler
  • Vaccine against papillomatous digital dermatitis (PDD)
    Patent number: 6287575
    Abstract: This invention relates to the diagnosis and prevention of ungulate diseases caused by the spirochete bacteria Treponema. The invention specifically relates to isolated cultures of this spirochete and isolated nucleic acids and proteins.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: September 11, 2001
    Assignee: The Regents of the University of California
    Inventors: Richard L. Walker, Deryck H. Read, David W. Hird, Rance B. Lefebvre, Steven L. Berry, James S. Cullor, Hank M. Lefler
  • Vaccine against papillomatous digital dermatitis (PDD)
    Patent number: 6096323
    Abstract: This invention relates to the diagnosis and prevention of ungulate diseases caused by the spirochete bacteria Treponema. The invention specifically relates to isolated cultures of this spirochete and isolated nucleic acids and proteins.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: August 1, 2000
    Assignee: The Regents of the University of California
    Inventors: Richard L. Walker, Deryck H. Read, David W. Hird, Rance B. Lefebvre, Steven L. Berry, James S. Cullor, Hank M. Lefler
  • Methods and compositions for diagnosing lyme disease
    Patent number: 5977339
    Abstract: A chromosomal gene of Borrelia burgdorferi which encodes a conserved antigen of approximately 79 kD has been isolated and sequenced. The chromosomal gene, the gene product, and antibodies to the gene product may be used in diagnostic methods for the detection of Borrelia burgdorferi infection. The antigen and fragments thereof are suitable for use in vaccine compositions and methods.
    Type: Grant
    Filed: January 17, 1997
    Date of Patent: November 2, 1999
    Assignee: The Regents of the University of California
    Inventors: Rance B. LeFebvre, Guey-Chen Perng
  • Methods and compositions for diagnosing lyme disease
    Patent number: 5324630
    Abstract: A chromosomal gene of Borrelia burgdorferi which encodes a conserved antigen of approximately 79 kD has been isolated and sequenced. The chromosomal gene, the gene product, and antibodies to the gene product may be used in diagnostic methods for the detection of Borrelia burgdorferi infection. The antigen and fragments thereof are suitable for use in vaccine compositions and methods.
    Type: Grant
    Filed: June 28, 1991
    Date of Patent: June 28, 1994
    Assignee: The Regents of the University of California
    Inventors: Rance B. LeFebvre, Guey-Chuen Perng